To conclude, the NSCLC patients with lymph node metastases are characterized by the high density of intratumoral-infiltrating CD8+ T cells and more immunosuppressive TME-approaching CD8+ T cells [49]. This evidence concerns the gene CD8A and metastatic malignant neoplasm in the lymph nodes.